Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

Deletion of One 23S rRNA Gene (rrl) Copy Contributes to the Development of Linezolid Resistance in Staphylococcus warneri

Caroline Rouard, Florence Doucet-Populaire, Christelle Guillet-Caruba, Millie Villet, Nadège Bourgeois-Nicolaos
Caroline Rouard
aAP-HP, Hôpital Antoine Béclère, Service de Bactériologie-Hygiène, Clamart, France
bEA4043, Bactéries Pathogènes et Santé, Faculté de Pharmacie, Université Paris Saclay, Chatenay-Malabry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florence Doucet-Populaire
aAP-HP, Hôpital Antoine Béclère, Service de Bactériologie-Hygiène, Clamart, France
bEA4043, Bactéries Pathogènes et Santé, Faculté de Pharmacie, Université Paris Saclay, Chatenay-Malabry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christelle Guillet-Caruba
aAP-HP, Hôpital Antoine Béclère, Service de Bactériologie-Hygiène, Clamart, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Millie Villet
aAP-HP, Hôpital Antoine Béclère, Service de Bactériologie-Hygiène, Clamart, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadège Bourgeois-Nicolaos
aAP-HP, Hôpital Antoine Béclère, Service de Bactériologie-Hygiène, Clamart, France
bEA4043, Bactéries Pathogènes et Santé, Faculté de Pharmacie, Université Paris Saclay, Chatenay-Malabry, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.01139-18
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

Staphylococcus warneri, one of the emerging coagulase-negative staphylococci, may be responsible for bone and joint infections (1–3), for which linezolid (LZD) seems to be a good alternative treatment (4, 5). LZD resistance is related to mutations in domain V of 23S rRNA (rrl), in ribosomal proteins L3 and L4, and to cfr and optrA genes (6, 7). In this report, we explored the possibilities and consequences of the emergence of LZD resistance in S. warneri, since it has not been previously published.

Three independent LZD resistance selections were performed in vitro (8) with an S. warneri isolate (SW0; LZD MIC = 0.5 mg/liter) from a case of monomicrobial diabetic foot osteitis. We obtained LZD-resistant mutants for all selections (MIC = 64 mg/liter). Resistance-associated mutations occurred in the three selections with identical timelines, first with G152D in L3 and then with G2576T in rrl (Table 1) (9). The mutation G2576T is the most frequently described mutation in clinical LZD-resistant staphylococci, and G152D has also been previously reported (6, 10). Small differences occurred, with a K68N mutation in L3 in the third selection and the reversion of the G152D mutation in the first selection (Table 1). Mutations in ribosomal proteins were not associated with a significant LZD resistance (MIC ≤ 4 mg/liter) (8, 11). A specific PCR described for Staphylococcus aureus was used to determine the rRNA operon (rrn) copy number (12), and the number of mutated rrl copies was inferred from pyrosequencing (Pyromark; Qiagen) (13) or whole-genome sequencing (MiSeq; Illumina). The MIC increase to 64 mg/liter was associated with an increase in mutated rrl copies and with the deletion of 1 of the 6 rrn copies (Table 1; Fig. 1). This loss always involved the third operon (12).

View this table:
  • View inline
  • View popup
TABLE 1

LZD resistance-associated mutations, number of SNPs, and generation time increase among sequenced mutants, in comparison with parental strain SW0a

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Correlation of LZD resistance-associated mutations and increase in generation time. Gray ovals represent L3 and L4 ribosomal protein mutations, and black ovals represent the rrl mutation.

Various biological costs (BCs) were observed throughout the selections. In the first and second selections, a weak BC was observed, in contrast to the third selection, where an important increase in generation time of up to 40% appeared when 60% of the rrl copies harbored the G2576T mutation (Fig. 1). A small-colony variant (SCV) phenotype also appeared concomitantly. These differences among selections could be related to the L4 K68N mutation in the third selection, in association with perturbation of the three-dimensional structure of 23S rRNA (14) or to additional mutations. A whole-genome single-nucleotide polymorphism (SNP) analysis was performed after de novo assembly of the parental LZD-susceptible strain (SW0) (BioNumerics; Applied Maths). We observed one or two supplementary SNPs (apart from resistance-associated mutations) in mutants SW1-16 and SW2-17 without a BC and four SNPs in mutant SW3-36 with a BC (Table 1). Therefore, the BC and SCV phenotype may be due to additional mutations. We observed the T70K mutation in RelA/SpoT, which is a hydrolase/synthase enzyme for (p)ppGpp (Table 2). Gao et al. have shown in S. aureus that the F128Y mutation, localized in the N-terminal hydrolase domain of the RelA hydrolase, like our mutation, was also associated with reduced growth and an SCV phenotype (15). Moreover, a mutation leading to a codon stop in the sigB gene encoding the alternative sigma factor that is involved in bacterial metabolism regulation was observed (Table 2). The possible relationship with the observed phenotype should be further explored.

View this table:
  • View inline
  • View popup
TABLE 2

Amino acid change analysis among sequenced mutants, in comparison with parental strain SW0

We described for the first time the genome modification of S. warneri under LZD pressure without BC and with the systematic loss of the third rrn operon associated with the increase in LZD resistance level. These features might require caution when using LZD in monotherapy.

Accession number(s).The sequencing raw data for each isolate were submitted to GenBank under BioProject record number PRJNA473123.

ACKNOWLEDGMENTS

We thank Delphine Guirlich for technical assistance and Anita Owens for English editing.

We declare no conflicts of interest.

  • Copyright © 2018 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Campoccia D,
    2. Montanaro L,
    3. Visai L,
    4. Corazzari T,
    5. Poggio C,
    6. Pegreffi F,
    7. Maso A,
    8. Pirini V,
    9. Ravaioli S,
    10. Cangini I,
    11. Speziale P,
    12. Arciola CR
    . 2010. Characterization of 26 Staphylococcus warneri isolates from orthopedic infections. Int J Artif Organs 33:575–581. doi:10.1177/039139881003300903.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Legius B,
    2. Landuyt KV,
    3. Verschueren P,
    4. Westhovens R
    . 2012. Septic arthritis due to Staphylococcus warneri: a diagnostic challenge. Open Rheumatol J 6:310–311. doi:10.2174/1874312901206010310.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. De Vecchi E,
    2. George DA,
    3. Romanò CL,
    4. Pregliasco FE,
    5. Mattina R,
    6. Drago L
    . 2018. Antibiotic sensitivities of coagulase-negative staphylococci and Staphylococcus aureus in hip and knee periprosthetic joint infections: does this differ if patients meet the International Consensus Meeting Criteria? Infect Drug Resist 11:539–546. doi:10.2147/IDR.S151271.
    OpenUrlCrossRef
  4. 4.↵
    1. Lovering AM,
    2. Zhang J,
    3. Bannister GC,
    4. Lankester BJA,
    5. Brown JHM,
    6. Narendra G,
    7. MacGowan AP
    . 2002. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother 50:73–77. doi:10.1093/jac/dkf066.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Rana B,
    2. Butcher I,
    3. Grigoris P,
    4. Murnaghan C,
    5. Seaton RA,
    6. Tobin CM
    . 2002. Linezolid penetration into osteo-articular tissues. J Antimicrob Chemother 50:747–750. doi:10.1093/jac/dkf207.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Pfaller MA,
    2. Mendes RE,
    3. Streit JM,
    4. Hogan PA,
    5. Flamm RK
    . 2017. Five-year summary of in vitro activity and resistance mechanisms of linezolid against clinically important gram-positive cocci in the United States from the LEADER Surveillance Program (2011 to 2015). Antimicrob Agents Chemother 61:e00609-17. doi:10.1128/AAC.00609-17.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Pfaller MA,
    2. Mendes RE,
    3. Streit JM,
    4. Hogan PA,
    5. Flamm RK
    . 2017. ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries. J Antimicrob Chemother 72:3093–3099. doi:10.1093/jac/dkx251.
    OpenUrlCrossRef
  8. 8.↵
    1. Rouard C,
    2. Aslangul E,
    3. Rivière A,
    4. Deback C,
    5. Butel M-J,
    6. Doucet-Populaire F,
    7. Bourgeois-Nicolaos N
    . 2017. Mutation in the L3 ribosomal protein could be associated with risk of selection of high-level linezolid-resistant Staphylococcus epidermidis strains. Microb Drug Resist 23:462–467. doi:10.1089/mdr.2016.0137.
    OpenUrlCrossRef
  9. 9.↵
    1. Bourgeois-Nicolaos N,
    2. Massias L,
    3. Couson B,
    4. Butel M,
    5. Andremont A,
    6. Doucet-Populaire F
    . 2007. Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo. J Infect Dis 195:1480–1488. doi:10.1086/513876.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Locke JB,
    2. Hilgers M,
    3. Shaw KJ
    . 2009. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother 53:5265–5274. doi:10.1128/AAC.00871-09.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    The European Committee on Antimicrobial Susceptibility. 2018. Breakpoint tables for interpretation of MICs and zone diameters, 2018. http://www.eucast.org.
  12. 12.↵
    1. Fluit AC,
    2. Jansen M,
    3. Bosch T,
    4. Jansen WTM,
    5. Schouls L,
    6. Jonker MJ,
    7. Boel CHE
    . 2016. rRNA operon copy number can explain the distinct epidemiology of hospital-associated MRSA. Antimicrob Agents Chemother 60:7313–7320. doi:10.1128/AAC.01613-16.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Decousser J-W,
    2. Desroches M,
    3. Bourgeois-Nicolaos N,
    4. Potier J,
    5. Jehl F,
    6. Lina G,
    7. Cattoir V,
    8. Vandenesh F,
    9. Doucet-Populaire F, Microbs Study Group
    . 2015. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections. Int J Antimicrob Agents 46:622–630. doi:10.1016/j.ijantimicag.2015.07.022.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Wolter N,
    2. Smith AM,
    3. Farrell DJ,
    4. Schaffner W,
    5. Moore M,
    6. Whitney CG,
    7. Jorgensen JH,
    8. Klugman KP
    . 2005. Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob Agents Chemother 49:3554–3557. doi:10.1128/AAC.49.8.3554-3557.2005.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Gao W,
    2. Chua K,
    3. Davies JK,
    4. Newton HJ,
    5. Seemann T,
    6. Harrison PF,
    7. Holmes NE,
    8. Rhee H-W,
    9. Hong J-I,
    10. Hartland EL,
    11. Stinear TP,
    12. Howden BP
    . 2010. Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog 6:e1000944. doi:10.1371/journal.ppat.1000944.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Deletion of One 23S rRNA Gene (rrl) Copy Contributes to the Development of Linezolid Resistance in Staphylococcus warneri
Caroline Rouard, Florence Doucet-Populaire, Christelle Guillet-Caruba, Millie Villet, Nadège Bourgeois-Nicolaos
Antimicrobial Agents and Chemotherapy Oct 2018, 62 (11) e01139-18; DOI: 10.1128/AAC.01139-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Deletion of One 23S rRNA Gene (rrl) Copy Contributes to the Development of Linezolid Resistance in Staphylococcus warneri
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Deletion of One 23S rRNA Gene (rrl) Copy Contributes to the Development of Linezolid Resistance in Staphylococcus warneri
Caroline Rouard, Florence Doucet-Populaire, Christelle Guillet-Caruba, Millie Villet, Nadège Bourgeois-Nicolaos
Antimicrobial Agents and Chemotherapy Oct 2018, 62 (11) e01139-18; DOI: 10.1128/AAC.01139-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Staphylococcus warneri
coagulase-negative staphylococci
drug resistance mechanisms
linezolid
oxazolidinones
ribosomes

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596